Current Approaches in Drug Designing and Development
JCADD
Journals Menu
About Journal
Current Approaches in Drug Designing and Development (JCADD) is an interdisciplinary, peer reviewed open access journal that publishes the highest quality scientific articles amalgamating broad range of fields including molecular modelling, clinical research and drug discovery and delivery.
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.
Aim and Scope
JCADD journal focuses on the latest research in all related fields of drug targets, rational drug discovery, computer-aided drug design and the different types of drug design, development methods. Patient safety, clinical outcomes, programs for the development, safety, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, quality by design, Design for reliability in drug development. bayesian sequential design for multi-regional design, design and analysis for target clinical trials, design and analysis for diagnostic procedures, Adaptive design for early clinical development, design for biosimilar studies, design for bioassay development and validation, design for statistical genetics, design for assessment of drug to drug interaction, design for bridging studies, design for stability analysis, etc.
JCADD journal welcomes authors to submit articles in any format like research, review opinions, new, short communication, mini review, perspective, commentary, etc. in the field of drug designing and development from any corner across globe.
Editorial Managing Policy
JCADD is using Editorial Manager Policy to attain quality in review process. This Policy follows an online manuscript submission, review and tracking systems. Review processing is performed by journal editorial board members or by outside experts. Editorial Managing Policy simplifies the publication process and helps the author to get track of their articles.
JCADD Open Access
As JCADD is an International Open Access journal, all the articles published under this journal will be accessible to all internet users throughout the world without any barrier of access under the terms of the Creative Commons Attribution License. All published articles will be assigned DOI provided by Cross Ref. JCADD will keep up-to- date with the latest advancements in the fields of Drug Designing.
Abstracts and Pdfs of all articles published are freely available to all interested online readers immediately after publication without any restrictions or any other subscriptions to researchers worldwide.
Authors are welcome to submit the manuscript through our online portal and or send us an E-mail attachment to our Editorial Office.
Journal Highlights
- Cheminformatics
- Clinical and Medicinal Chemistry
- Combinatorial Library Design
- Database Mining And Data Analysis
- Docking
- Drug Analytics
- Drug Biochemistry
- Drug Chemistry
- Drug Designing
- Drug Development
- Drug Discovery
- Drug Extraction Studies
- Drug Safety Assessment
- Homology Modeling
- Immunology& Clinical Toxicology
- Ligand Design
- Ligand-Based Drug Design
- Medicinal Chemistry
- Molecular Docking
- Molecular Mechanics
- Quantum Mechanics
- Molecular Modeling
- Molecular Modification
- Organic chemistry
- Orphan Drug
- Pharmaceutical Analysis
- Pharmaceutical Chemistry
- Pharmacology
- Pharmacology and Clinical Pharmacy
- Pharmacophore Modeling in Drug Design
- Pre-Clinical Development
- Product Development
- Qsar
- Rational Drug Design
- Protein Modeling And Structural Genomics
- Qm Simulations in Biomacromolecules
- Retrometabolic Drug Design
- Reverse Transcriptase inhibitors
- Screening
- Structure-Based Drug Design
- Structure-Based Molecular Design
- Target Prediction
- Pharmacophores
- Pharmacovigilance
- Phases of Drug Development
- Physiologically-based pharmacokinetic modelling
- Posology
- Preclinical Drug Development
- Prodrug
- Protease Substrate/Inhibitor
- Protein modeling and Structural genomics
- Psychopharmacology
- Quantitative structure-activity Relationship (QSAR)
- Receptor Agonist/ Antagonist
- Screening and Drug Design
- Simcyp Simulator
- Structure-activity Relationships
- Structure-Based Molecular Design
- Synthetic Chemistry
- Target prediction
- Therapeutic Window
- Translational Drug Development
Plagiarism Check
Olites undergoes plagiarism check through ithenticate
a 
